diabetes mellitus preoperative glucose glycaemic control suikerziekte preoperatief
Conditions
Interventions
On the day of preoperative consultation, HbA1c will be measured. Patients with an HbA1c =53 mmol/mol will be randomised to an intervention group or control group.
Patients in the intervention group w
Sponsors
Academic Medical Center
Eligibility
Inclusion criteria
Inclusion criteria: - Diabetes mellitus type 2 (diagnosis at least 3 months prior to pre-operative screening) - Age 18 - 85 years - Elective non-cardiac surgery - Scheduled for surgery at least 7 days from date of screening - Informed consent
Exclusion criteria
Exclusion criteria: - Bariatric surgery - Palliative surgery - Outpatient or day case surgery - (Potentially) pregnant or breast-feeding - Unable to communicate in Dutch or English, psychiatric disorder, known therapy incompliance or deemed unfit by the researchers for another reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study will be the number of days at home up to 30 days after surgery (DAH30), which is a single, pragmatic, patient-centred outcome. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are preoperative and postoperative blood glucose concentrations, incidence of hyperglycaemia and hypoglycaemia (glucose >10 mmol/l or <4 mmol/l, respectively) and change from baseline HbA1c, fructosamine, and 1,5- anhydroglucitol. | — |
Contacts
Public ContactA.H. Hulst
Academisch Medisch Centrum Postbus 22660
Outcome results
None listed